Aleje Jerozolimskie 65/79, 00-697 Warsaw, Poland

Dupuytren’s Contracture Market Brief Insights on Diagnosis, Types, Drug and Clinical Review Analysis 2019


Dupuytren’s Contracture Market Brief Insights on Diagnosis, Types, Drug and Clinical Review Analysis 2019

Dupuytren’s ContracturePress Release

Dupuytren’s Contracture Market Information: By Types (Type I, Type II, Type III) By Diagnosis (Physical Examination, X-Ray, others) By Surgery (Needle Aponeurotomy (NA), others), Drug (Steroids, Collagenase Injection, others) By Therapy, and By End User – Global Forecast till 2023


Dupuytren’s contracture is a condition primarily of the fingers of the hand in which there is difficulty in articulating fingers due to formation of knots of tissue form under the skin which may worsen to a degree that fingers become permanently bent in a flexed position.

The exact causes of Dupuytren’s contracture are unknown however the risk factors include alcoholism, smoking, thyroid problems, liver disease, diabetes, previous hand trauma, epilepsy, family history etc. Dupuytren’s contracture has a higher rate in males over the age of 50.

There is also a genetic propensity with Caucasians being affected more while it is rare among Asians and Africans. Dupuytren’s contracture has a regress rate of approximately 10 % of patients. The annual incidence proportion of this disease was estimated at about 3 cases per 10,000 adults. The occurrence rate in the United States is about 5% of people, while Scandinavian nations has a higher rate of about 30% of men over 60 years old have the condition.

Avail Free sample [email protected]

Needle aponeurotomy (NA) is the preferred surgical treatment of choice and used in the majority of patients. It is less invasive than the open hand surgery which is now reserved for the most severe conditions. The collagenase injection segment is however expected to grow the fastest due to minimum invasive nature and the lesser hospitalization stay.

Market Key Players:

Key players profiled in the report are Bristol-Meyers Squibb Co, Fresenius Kabi, Merck & Company, Pfizer Inc., West-Ward Pharmaceuticals, Spear Pharmacueticals, Actiza Pharmaceutical Private Limited, Nantong Jinghua Pharmaceutical Co., Ltd., Endo International plc. Pfizer Inc., and others.


The global Dupuytren’s contracture market has been segmented on the basis of types, diagnosis, surgery, drugs, therapy and end users.

Based on type, the market has been segmented as type I, type II, type III.

Based on diagnosis, the market has been segmented as physical examination, x-ray and others.

Based on drug, the market has been segmented as steroids, collagenase injection, immune-modulators and others.

Based on therapy, the market has been segmented as radiation therapy, physiotherapy and others.

Based on the end user, the market has been segmented as hospitals & clinics, academic and research and others.

Brows Complete Research [email protected]

Table of Content

  1. Report Prologue
  2. Introduction
  3. Research Methodology
  4. Market Dynamics
  5. Market Factor Analysis

5.1 Value Chain Analysis

5.2 PORTERS Five Forces

5.3 Demand & Supply: Gap Analysis

5.4 Pricing Analysis

5.5 Investment Opportunity Analysis

5.6 Merger And Acquisition Landscape

5.7 Upcoming Trends

5.7.1 Market Trends

5.7.2 Technological Trends

5.7.3 Insurance & Regulations

5.7.4 Others

  1. Scleritis Market By Types
  2. Scleritis Market By Treatment
  3. Scleritis Market By Region


Regional Analysis

Europe account for a significant market share owing to extensive use of medications and high expenditure on the health care. Additionally, the greater prevalence of Dupuytren’s contracture in Europe drives the Dupuytren’s contracture market. Also, concentration of major research companies in the developed countries of this region is adding fuel to the market growth. The highly developed healthcare system of the Scandavanian region coupled with high expenditure on healthcare, cruises the sale of Dupuytren’s contracture treatment. Europe is led by countries such as Germany and France. Norway is expected to be the fastest growing market.

US is the second largest market in the world due to high income and healthcare penetration. The presence of large healthcare players in the US benefits the market coupled with the high public expenditure on healthcare which comes to be approximately 16 % of the GDP. Asia Pacific region is expected to grow at a slower rate with China and India are likely to lead this market due to fast growing healthcare sector during the forecast period. The lower prevalence of Dupuytren’s contracture in the Asian populations acts as a drag on the market.

And Many More

Inquire for Exclusive discount at

The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.


Market Research Future

+1 646 845 9312

Email: [email protected]

Tags: , , , , , , , , , , ,